Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)
Media ReleaseCOPENHAGEN, Denmark; June 15, 2025 Results from the EPCORE® NHL-2 trial…
Sarepta Provides Safety Update for ELEVIDYS and Initiates Steps to Strengthen Safety in Non-Ambulatory Individuals with Duchenne
- The Company is developing an enhanced immunosuppressive regimen in consultation with…
PlayLA Launches Summer Season of Youth Sports, Inspiring Olympic Spirit Across Los Angeles
LOS ANGELES--(BUSINESS WIRE)--This summer, PlayLA Youth & Adaptive Youth Sports Program, the…
Explore Launches to Transform International Undergraduate Student Recruitment
New independent brand, Explore, powered by Cialfo and BridgeU, offers universities access…
Biru Launches Birunoko PFP Collection and Expands in Japan with Soneium Collaboration
TAIPEI, May 26, 2025 /PRNewswire/ -- Biru by Lootex is an innovative platform…
New roles in Automobili Lamborghinis international commercial organization
The Sant’Agata Bolognese company announces a number of rotations and a new…
12BET Brings the Aviator Craze to Players with Spribe’s Trending Games
MUMBAI, India, May 22, 2025 /PRNewswire/ -- 12BET, a trusted name in…
Herbalife India Releases Second Episode of Podcast Series – Live Your Best Life, Unscripted
'Nutrition Simplified: Protein, Supplements, and Smarter Choices' with Dr. Parag Singhal and…
Writer Relocations Alerts Its Customers on Fraudulent Companies Misusing Its Brand Name
MUMBAI, India, May 20, 2025 /PRNewswire/ -- Writer Relocations, a global leader in…
Axonify Uncovers the Training Disconnect Facing Gen Z Frontline Workers
New data shows personalized, mobile-first learning is essential to retaining and engaging…